To catalogue

Dermapep™ A350

Dermapep™ A350 has been demonstrated in vitro by measuring MMP1 production on Hs68 fibroblast cell line.DermapepTM A350 significantly decreased MMP-1 production under both non-stimulated and UV-stimulated condition. Dermapep™ A350 also considerably restored the production of type I procollagen from UVA induced damage (supplementary data were not shown).

Product families

Applications

Personal Care — Beauty & Care
  • Skin Care

Product Families

Cosmetic Ingredients — Cosmetic Actives
  • Skin Actives

Other characteristics

Brand
Miwon Commercial Company Ltd. Dermapep
Carrier
Butylene Glycol
Markets
Personal Care
Appearance
Transparent Solution
Technology
Cosmetic Ingredients

Technical data

Table 1 of 1

1 row
CharacteristicValueUnit
Active Content0.1%

The Omnichem website uses cookies. By continuing to use the site, you consent to their use in accordance with our Privacy Policy and to the collection of analytics.